It appears that both humoral and cellular immunity contribute to COVID-19 clearance during primary infection, which is in agreement with patient studies showing a connection between clinical outcomes and a robust coordinated adaptive response in which CD4+ T cells, CD8+ T cells, and antibodies are often required [59]. The gene discussed is CD8A; the disease is COVID-19.